Poly Medicure Ltd
NSE:POLYMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 390.55
3 128.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Poly Medicure Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | IN |
Market Cap | 261.5B INR |
Gross Margin |
67%
|
Country | JP |
Market Cap | 6.8T JPY |
Gross Margin |
86%
|
Country | CH |
Market Cap | 37.9B CHF |
Gross Margin |
55%
|
Country | DK |
Market Cap | 200.9B DKK |
Gross Margin |
68%
|
Country | US |
Market Cap | 16.9B USD |
Gross Margin |
70%
|
Country | KR |
Market Cap | 9.9T KRW |
Gross Margin |
15%
|
Country | CA |
Market Cap | 6.9B USD |
Gross Margin |
61%
|
Country | CN |
Market Cap | 48.6B CNY |
Gross Margin |
73%
|
Country | US |
Market Cap | 6.3B USD |
Gross Margin |
65%
|
Country | US |
Market Cap | 6.1B USD |
Gross Margin |
47%
|
Country | UK |
Market Cap | 4.8B GBP |
Gross Margin |
56%
|
Poly Medicure Ltd
Glance View
Poly Medicure Ltd. engages in the provision and sales of medical devices. The company is headquartered in Faridabad, Haryana. The company went IPO on 2011-12-05. The firm is primarily in the business of manufacture and sale of medical devices. The firm offers a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. The company supplies its products to approximately 110 countries, in Europe, Africa, Americas, Australia, and Asia. Its products include suction control valve, safety arterial cannula, VTM Kit, VLTM kit, blood collection needle with flashback, and pre-filled syringes. The firm operate eight manufacturing facilities across India, China, Egypt, and Italy. In India, it operates five manufacturing facilities, three of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand).
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Poly Medicure Ltd's most recent financial statements, the company has Gross Margin of 66.5%.